News
- 2022.06.30 RESEARCHES Update on Overseas Regulatory Review
-
2022.06.13
RESEARCHES
Generation of hypoimmunogenic induced pluripotent stem cells by CRISPR-Cas9 system and detailed evaluation for clinical application
-
2022.03.15
RESEARCHES
A Bridge from Japan to Korea:
CiRA Foundation's First Provision of Clinical-Grade iPS Cell Stock Overseas - 2021.12.24 OTHER Office Closed for New Year Holidays
- 2021.11.19 EVENT&SEMINARS Webinar for researchers
- 2021.11.15 OTHER Toward development of cell therapy for renal diseases using iPS cells -Joint research on the development of monitoring methods for the quality and manufacturing processes of nephron progenitor cells-
- 2021.10.22 OTHER CiRA Foundation Activity Report Vol.2
- 2021.08.27 EVENT&SEMINARS Webinar for researchers
- 2021.08.12 OTHER Appointment of Shinya Yamanaka, Representative Director of CiRA Foundation, as the chair the Scientific Advisory Board of Orizuru Therapeutics Inc.
- 2021.08.05 RESEARCHES Free provision of iPS cells made from 6 COVID-19 convalescent patients